Genuv is a biotech venture focused on tackling the challenges in areas such as neurodegenerative disorders, cancer, and autoimmune diseases. With a strong emphasis on high unmet needs in medical and technological complexities, Genuv aims to develop a variety of platform technologies to address these issues. By combining scientific imagination, creative technology, and exceptional capabilities, Genuv is dedicated to tackling the challenging tasks in the field of biomedicine.

Our core values of creativity, humility, authenticity, and generosity drive all our activities. When it comes to neurodegenerative diseases, Genuv seeks to stimulate and grow intrinsic neural stem cells, as well as restore the homeostasis of the central nervous system, aiming to go beyond conventional approaches that focus solely on symptoms, but instead aim to restore the functionality of the central nervous system. Genuv also strives to discover therapeutic agents that normalize the body's immune system by targeting immune cells that play a crucial role in specific disease microenvironments associated with cancer and autoimmune diseases.

Our proprietary platforms include the ATRIVIEW® CNS Drug Screening Platform and the SHINE MOUSE® and NuvoMab™ Platform for generating antibodies against challenging targets in the fields of immunology and cancer. These platforms offer a novel approach that goes beyond traditional drug discovery strategies. In addition to phenotype screening, we also conduct target-based research to understand the mechanism and biomarkers of action.

With our mouse platform technology, we not only generate antibodies but also optimize them for difficult epitopes, strategically addressing issues such as low immunogenicity and high homology. Our goal is to generate antibodies against antigens that have been challenging to develop. With a leadership team possessing deep scientific backgrounds and extensive experience in neuroscience, oncology, immunology, as well as IP law and business development, Genuv is well-equipped to make significant contributions to drug development and innovation.

Our advisory board consists of renowned researchers, scholars, and innovators who have made substantial contributions to basic research, drug development, and innovation across the life sciences. For more information, please visit our website or contact us through the provided email addresses